| 引用本文: | 李刚;刘鹏;刘诚迅;王钊1.我国细胞工程制药的研究现状和发展前景[J].中国现代应用药学,2002,(4):278-281. |
| Li Gang (Li G), Liu Peng (Liu P), Liu Chengxun (Liu CX), Wang Zhao (Wang Z) 1.Present and Prosjecting of Cell Engineering Pharmacy in China[J].Chin J Mod Appl Pharm(中国现代应用药学),2002,(4):278-281. |
|
|
| 摘要: |
|
| 关键词: 细胞工程 细胞融合 核移植 染色体改造 转基因 细胞培养 |
| DOI： |
| 分类号: |
| 基金项目:清华大学·香港浸会大学中药现代化研究联合实验室和清华大学 985计划的支持 |
|
| Present and Prosjecting of Cell Engineering Pharmacy in China |
|
Li Gang (Li G), Liu Peng (Liu P), Liu Chengxun (Liu CX), Wang Zhao (Wang Z) 1
|
| Abstract: |
| OBJECTIVE:To review the present and prospecting of cell engineering pharmacy in China.METHOD:According to the recent literatures on this field, animal cell engineering and plant cell engineering pharmacy were summarized and evaluated.RESULTS:Cell engineer |
| Key words: cell engineering pharmacy, traditional Chinese medicine, transgene, biological reactor |
